BlackRock Inc. - FIVE PRIME THERAPEUTICS INC ownership

FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 131 filers reported holding FIVE PRIME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$116,083,000
+130.6%
3,081,587
+4.1%
0.00%
+50.0%
Q4 2020$50,333,000
+405.4%
2,959,031
+39.6%
0.00%
Q3 2020$9,960,000
-25.1%
2,119,146
-2.8%
0.00%
-100.0%
Q2 2020$13,301,000
+130.6%
2,180,375
-14.2%
0.00%
Q1 2020$5,768,000
-50.4%
2,541,227
+0.2%
0.00%
Q4 2019$11,640,000
+1.6%
2,535,819
-14.2%
0.00%
Q3 2019$11,456,000
-34.1%
2,956,303
+2.6%
0.00%
-100.0%
Q2 2019$17,382,000
-54.0%
2,882,588
+2.3%
0.00%
-50.0%
Q1 2019$37,773,000
+33.6%
2,818,954
-7.3%
0.00%
+100.0%
Q4 2018$28,269,000
-30.3%
3,039,915
+4.4%
0.00%
-50.0%
Q3 2018$40,536,000
-10.5%
2,912,138
+1.7%
0.00%0.0%
Q2 2018$45,271,000
-0.7%
2,863,520
+7.9%
0.00%0.0%
Q1 2018$45,585,000
-5.3%
2,653,489
+20.8%
0.00%0.0%
Q4 2017$48,139,000
-47.5%
2,196,109
-1.9%
0.00%
-60.0%
Q3 2017$91,619,000
+37.5%
2,239,517
+1.2%
0.01%
+25.0%
Q2 2017$66,609,000
-16.0%
2,212,178
+0.8%
0.00%0.0%
Q1 2017$79,323,000
+25002.2%
2,194,289
+34713.4%
0.00%
Q4 2016$316,000
-51.6%
6,303
-49.3%
0.00%
-100.0%
Q3 2016$653,000
+23.7%
12,431
-2.6%
0.00%0.0%
Q2 2016$528,000
+568.4%
12,768
+562.9%
0.00%
Q1 2016$79,000
+119.4%
1,926
+118.4%
0.00%
Q4 2015$36,000
+414.3%
882
+107.0%
0.00%
Q3 2015$7,000
-36.4%
4260.0%0.00%
Q2 2015$11,000
+10.0%
4260.0%0.00%
Q1 2015$10,000
-16.7%
4260.0%0.00%
Q4 2014$12,000
+140.0%
4260.0%0.00%
Q3 2014$5,000
-28.6%
4260.0%0.00%
Q2 2014$7,0004260.00%
Other shareholders

There were no reported owners of FIVE PRIME THERAPEUTICS INC in Q4 2020.

NameSharesValueWeighting ↓
View complete list of FIVE PRIME THERAPEUTICS INC shareholders